{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:20:16Z","timestamp":1791091216557,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R21DK105405"],"award-info":[{"award-number":["R21DK105405"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013015","name":"Cedars-Sinai Medical Center","doi-asserted-by":"crossref","award":["Doris Factor Molecular Endocrinology Laboratory"],"award-info":[{"award-number":["Doris Factor Molecular Endocrinology Laboratory"]}],"id":[{"id":"10.13039\/100013015","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11102-018-0864-8","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T13:22:10Z","timestamp":1516195330000},"page":"183-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Silent corticotroph adenomas"],"prefix":"10.1007","volume":"21","author":[{"given":"Anat","family":"Ben-Shlomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odelia","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"issue":"2","key":"864_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156(2):203\u2013216. \n                    https:\/\/doi.org\/10.1530\/eje.1.02326","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"864_CR2","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/cen.13146","volume":"85","author":"KB Guttenberg","year":"2016","unstructured":"Guttenberg KB, Mayson SE, Sawan C, Kharlip J, Lee JY, Martinez-Lage M, Loevner LA, Ewanichak J, Grady MS, Snyder PJ (2016) Prevalence of clinically silent corticotroph macroadenomas. Clin Endocrinol 85(6):874\u2013880. \n                    https:\/\/doi.org\/10.1111\/cen.13146","journal-title":"Clin Endocrinol"},{"issue":"3","key":"864_CR3","first-page":"347","volume":"29","author":"M Pawlikowski","year":"2008","unstructured":"Pawlikowski M, Kunert-Radek J, Radek M (2008) \u201cSilent\u201d corticotropinoma. Neuro Endocrinol Lett 29(3):347\u2013350 pii]","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"864_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M, Hiniker A, Chang EF, Kunwar S, Blevins L, Aghi MK (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73(1):8\u201317. \n                    https:\/\/doi.org\/10.1227\/01.neu.0000429858.96652.1e\n                    \n                   (discussion 17\u201318)","journal-title":"Neurosurgery"},{"issue":"1","key":"864_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-10-0076","volume":"163","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Jouanneau E, Auger C, Borson-Chazot F, Lachuer J, Pugeat M, Trouillas J (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing\u2019s disease. Eur J Endocrinol 163(1):35\u201343. \n                    https:\/\/doi.org\/10.1530\/EJE-10-0076","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"864_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","volume":"72","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol 72(5):648\u2013653. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03673.x","journal-title":"Clin Endocrinol"},{"issue":"3","key":"864_CR7","first-page":"617","volume":"98","author":"E Horvath","year":"1980","unstructured":"Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 98(3):617\u2013638","journal-title":"Am J Pathol"},{"issue":"1","key":"864_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/02688690500081230","volume":"19","author":"SE Baldeweg","year":"2005","unstructured":"Baldeweg SE, Pollock JR, Powell M, Ahlquist J (2005) A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg 19(1):38\u201342. \n                    https:\/\/doi.org\/10.1080\/02688690500081230","journal-title":"Br J Neurosurg"},{"issue":"3","key":"864_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M, Takeshita A, Morita K, Takano K, Sano T (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580\u2013584. \n                    https:\/\/doi.org\/10.1227\/01.NEU.0000290906.53685.79\n                    \n                   (discussion 584-585)","journal-title":"Neurosurgery"},{"issue":"2","key":"864_CR10","doi-asserted-by":"publisher","first-page":"E15","DOI":"10.3171\/2014.11.FOCUS14679","volume":"38","author":"M Zoli","year":"2015","unstructured":"Zoli M, Faustini-Fustini M, Mazzatenta D, Marucci G, De Carlo E, Bacci A, Pasquini E, Lanzino G, Frank G (2015) ACTH adenomas transforming their clinical expression: report of 5 cases. Neurosurg Focus 38(2):E15. \n                    https:\/\/doi.org\/10.3171\/2014.11.FOCUS14679","journal-title":"Neurosurg Focus"},{"key":"864_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0844-4","author":"F Langlois","year":"2017","unstructured":"Langlois F, Lim DST, Yedinak CG, Cetas I, McCartney S, Cetas J, Dogan A, Fleseriu M (2017) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0844-4","journal-title":"Pituitary"},{"issue":"4","key":"864_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355. \n                    https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"key":"864_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12022-017-9498-z","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO Classification of Pituitary Tumors. Endocr Pathol. \n                    https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Endocr Pathol"},{"issue":"7","key":"864_CR14","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1210\/jc.2002-021934","volume":"88","author":"S Vallette-Kasic","year":"2003","unstructured":"Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, Enjalbert A, Drouin J, Brue T (2003) Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 88(7):3050\u20133056. \n                    https:\/\/doi.org\/10.1210\/jc.2002-021934","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"864_CR15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1530\/EJE-07-0428","volume":"157","author":"T Tateno","year":"2007","unstructured":"Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y (2007) Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Eur J Endocrinol 157(6):717\u2013724. \n                    https:\/\/doi.org\/10.1530\/EJE-07-0428","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"864_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1210\/jcem.81.2.8636257","volume":"81","author":"S Gibson","year":"1996","unstructured":"Gibson S, Ray DW, Crosby SR, Dornan TL, Jennings AM, Bevan JS, Davis JR, White A (1996) Impaired processing of proopiomelanocortin in corticotroph macroadenomas. J Clin Endocrinol Metab 81(2):497\u2013502. \n                    https:\/\/doi.org\/10.1210\/jcem.81.2.8636257","journal-title":"J Clin Endocrinol Metab"},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF02738816","volume":"10","author":"E Horvath","year":"1999","unstructured":"Horvath E, Kovacs K, Lloyd RV (1999) Pars intermedia of the human pituitary revisited: morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol 10:55\u201364","journal-title":"Endocr Pathol"},{"issue":"3","key":"864_CR18","first-page":"227","volume":"6","author":"E Thodou","year":"2007","unstructured":"Thodou E, Argyrakos T, Kontogeorgos G (2007) Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas. Hormones 6(3):227\u2013232","journal-title":"Hormones"},{"issue":"2","key":"864_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF01600224","volume":"419","author":"L Stefaneanu","year":"1991","unstructured":"Stefaneanu L, Kovacs K, Horvath E, Lloyd RV (1991) In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas. Virchows Arch A 419(2):107\u2013113","journal-title":"Virchows Arch A"},{"issue":"3","key":"864_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0002-9343(78)90236-X","volume":"64","author":"K Kovacs","year":"1978","unstructured":"Kovacs K, Horvath E, Bayley TA, Hassaram ST, Ezrin C (1978) Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 64(3):492\u2013499","journal-title":"Am J Med"},{"issue":"4","key":"864_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1947601910370979","volume":"1","author":"T Hosoyama","year":"2010","unstructured":"Hosoyama T, Nishijo K, Garcia MM, Schaffer BS, Ohshima-Hosoyama S, Prajapati SI, Davis MD, Grant WF, Scheithauer BW, Marks DL, Rubin BP, Keller C (2010) a postnatal Pax7 progenitor gives rise to pituitary adenomas. Genes Cancer 1(4):388\u2013402. \n                    https:\/\/doi.org\/10.1177\/1947601910370979","journal-title":"Genes Cancer"},{"issue":"2","key":"864_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3171\/jns.1990.72.2.0262","volume":"72","author":"T Nagaya","year":"1990","unstructured":"Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, Nakane T, Sugita K, Matsui N (1990) Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing\u2019s disease. J Neurosurg 72(2):262\u2013267. \n                    https:\/\/doi.org\/10.3171\/jns.1990.72.2.0262","journal-title":"J Neurosurg"},{"issue":"3","key":"864_CR23","first-page":"232","volume":"11","author":"I Takumi","year":"1998","unstructured":"Takumi I, Steiner DF, Sanno N, Teramoto A, Osamura RY (1998) Localization of prohormone convertases 1\/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Mod Pathol 11(3):232\u2013238","journal-title":"Mod Pathol"},{"issue":"5","key":"864_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1507\/endocrj.K07-059","volume":"54","author":"T Tateno","year":"2007","unstructured":"Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K, Hirata Y (2007) Defective expression of prohormone convertase 1\/3 in silent corticotroph adenoma. Endocr J 54(5):777\u2013782","journal-title":"Endocr J"},{"issue":"4","key":"864_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/A:1025321731790","volume":"5","author":"S Ohta","year":"2002","unstructured":"Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H (2002) Significance of absent prohormone convertase 1\/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I\u2013immunohistochemical study. Pituitary 5(4):221\u2013223","journal-title":"Pituitary"},{"issue":"2","key":"864_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12020-016-1028-0","volume":"56","author":"A Righi","year":"2017","unstructured":"Righi A, Faustini-Fustini M, Morandi L, Monti V, Asioli S, Mazzatenta D, Bacci A, Foschini MP (2017) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1\/3. Endocrine 56(2):286\u2013297. \n                    https:\/\/doi.org\/10.1007\/s12020-016-1028-0","journal-title":"Endocrine"},{"issue":"4","key":"864_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1507\/endocrj.K08E-186","volume":"56","author":"T Tateno","year":"2009","unstructured":"Tateno T, Kato M, Tani Y, Oyama K, Yamada S, Hirata Y (2009) Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas. Endocr J 56(4):579\u2013584","journal-title":"Endocr J"},{"issue":"2","key":"864_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11102-011-0316-1","volume":"15","author":"F Gabalec","year":"2012","unstructured":"Gabalec F, Beranek M, Netuka D, Masopust V, Nahlovsky J, Cesak T, Marek J, Cap J (2012) Dopamine 2 receptor expression in various pathological types of clinically non-functioning pituitary adenomas. Pituitary 15(2):222\u2013226. \n                    https:\/\/doi.org\/10.1007\/s11102-011-0316-1","journal-title":"Pituitary"},{"issue":"4","key":"864_CR29","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-10-0245","volume":"163","author":"Y Tani","year":"2010","unstructured":"Tani Y, Inoshita N, Sugiyama T, Kato M, Yamada S, Shichiri M, Hirata Y (2010) Upregulation of CDKN2A and suppression of cyclin D1 gene expressions in ACTH-secreting pituitary adenomas. Eur J Endocrinol 163(4):523\u2013529. \n                    https:\/\/doi.org\/10.1530\/EJE-10-0245","journal-title":"Eur J Endocrinol"},{"issue":"1\u20132","key":"864_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2010.04.026","volume":"326","author":"A Righi","year":"2010","unstructured":"Righi A, Jin L, Zhang S, Stilling G, Scheithauer BW, Kovacs K, Lloyd RV (2010) Identification and consequences of galectin-3 expression in pituitary tumors. Mol Cell Endocrinol 326(1\u20132):8\u201314. \n                    https:\/\/doi.org\/10.1016\/j.mce.2010.04.026","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"864_CR31","first-page":"2251","volume":"63","author":"D Riss","year":"2003","unstructured":"Riss D, Jin L, Qian X, Bayliss J, Scheithauer BW, Young WF Jr, Vidal S, Kovacs K, Raz A, Lloyd RV (2003) Differential expression of galectin-3 in pituitary tumors. Cancer Res 63(9):2251\u20132255","journal-title":"Cancer Res"},{"issue":"6","key":"864_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAI.0000000000000108","volume":"23","author":"A Di Meo","year":"2015","unstructured":"Di Meo A, Rotondo F, Kovacs K, Cusimano MD, Syro LV, Di Ieva A, Diamandis EP, Yousef GM (2015) Human kallikrein 10 expression in surgically removed human pituitary corticotroph adenomas: an immunohistochemical study. Appl Immunohistochem Mol Morphol 23(6):433\u2013437. \n                    https:\/\/doi.org\/10.1097\/PAI.0000000000000108","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"864_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12022-013-9270-y","volume":"24","author":"O Mete","year":"2013","unstructured":"Mete O, Hayhurst C, Alahmadi H, Monsalves E, Gucer H, Gentili F, Ezzat S, Asa SL, Zadeh G (2013) The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas. Endocr Pathol 24(4):191\u2013198. \n                    https:\/\/doi.org\/10.1007\/s12022-013-9270-y","journal-title":"Endocr Pathol"},{"issue":"2","key":"864_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1227\/NEU.0b013e318230ac63","volume":"70","author":"F Salehi","year":"2012","unstructured":"Salehi F, Scheithauer BW, Kovacs K, Horvath E, Syro LV, Sharma S, Manoranjan B, Cusimano M (2012) O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas. Neurosurgery 70(2):491\u2013496. \n                    https:\/\/doi.org\/10.1227\/NEU.0b013e318230ac63\n                    \n                   (discussion 496)","journal-title":"Neurosurgery"},{"issue":"3","key":"864_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, Mao Y, Li YM, Hu RG, Zhang ZY, Ye HY, Shen M, Shou XF, Li ZQ, Peng H, Wang QZ, Zhou DZ, Qin XL, Ji J, Zheng J, Chen H, Wang Y, Geng DY, Tang WJ, Fu CW, Shi ZF, Zhang YC, Ye Z, He WQ, Zhang QL, Tang QS, Xie R, Shen JW, Wen ZJ, Zhou J, Wang T, Huang S, Qiu HJ, Qiao ND, Zhang Y, Pan L, Bao WM, Liu YC, Huang CX, Shi YY, Zhao Y (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25(3):306\u2013317. \n                    https:\/\/doi.org\/10.1038\/cr.2015.20","journal-title":"Cell Res"},{"issue":"7","key":"864_CR36","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferrau F, Nusser C, Kawaguchi K, Stratakis CA, Faucz FR, Wildemberg LE, Assie G, Beschorner R, Dimopoulou C, Buchfelder M, Popovic V, Berr CM, Toth M, Ardisasmita AI, Honegger J, Bertherat J, Gadelha MR, Beuschlein F, Stalla G, Komada M, Korbonits M, Reincke M (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing\u2019s disease. J Clin Endocrinol Metab 100(7):E997\u2013E1004. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1453","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"864_CR37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.molcel.2006.02.018","volume":"21","author":"F Huang","year":"2006","unstructured":"Huang F, Kirkpatrick D, Jiang X, Gygi S, Sorkin A (2006) Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Mol Cell 21(6):737\u2013748. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2006.02.018","journal-title":"Mol Cell"},{"issue":"3","key":"864_CR38","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1074\/jbc.M604711200","volume":"282","author":"HA Alwan","year":"2007","unstructured":"Alwan HA, van Leeuwen JE (2007) UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation. J Biol Chem 282(3):1658\u20131669. \n                    https:\/\/doi.org\/10.1074\/jbc.M604711200","journal-title":"J Biol Chem"},{"issue":"4","key":"864_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/MED.0000000000000344","volume":"24","author":"A Ben-Shlomo","year":"2017","unstructured":"Ben-Shlomo A, Cooper O (2017) Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside. Curr Opin Endocrinol Diabetes Obes 24(4):301\u2013305. \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000344","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"864_CR40","first-page":"2897","volume":"30","author":"B Manoranjan","year":"2010","unstructured":"Manoranjan B, Salehi F, Scheithauer BW, Rotondo F, Kovacs K, Cusimano MD (2010) Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas. Anticancer Res 30(7):2897\u20132904","journal-title":"Anticancer Res"},{"issue":"3","key":"864_CR41","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1385\/EP:16:3:195","volume":"16","author":"BW Scheithauer","year":"2005","unstructured":"Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, Lloyd RV (2005) The pituitary in Turner syndrome. Endocr Pathol 16(3):195\u2013200","journal-title":"Endocr Pathol"},{"issue":"2","key":"864_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","volume":"1","author":"O Cooper","year":"2010","unstructured":"Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S (2010) Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm Cancer 1(2):80\u201392. \n                    https:\/\/doi.org\/10.1007\/s12672-010-0014-x","journal-title":"Horm Cancer"},{"issue":"2","key":"864_CR43","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS, Mastrogianakis GM, Schniederjan MJ, Brat D, Pileggi AV, Oyesiku NM (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71(2):296\u2013303. \n                    https:\/\/doi.org\/10.1227\/NEU.0b013e318257c1f0\n                    \n                   (discussion 304)","journal-title":"Neurosurgery"},{"issue":"3","key":"864_CR44","first-page":"723","volume":"47","author":"BW Scheithauer","year":"2000","unstructured":"Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws ER Jr, Young WF Jr (2000) Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47(3):723\u2013729 (discussion 729-730)","journal-title":"Neurosurgery"},{"issue":"5","key":"864_CR45","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1227\/01.NEU.0000088660.16904.F7","volume":"53","author":"KM Webb","year":"2003","unstructured":"Webb KM, Laurent JJ, Okonkwo DO, Lopes MB, Vance ML, Laws ER Jr (2003) Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 53(5), 1076\u20131084 (discussion 1084-1075)","journal-title":"Neurosurgery"},{"issue":"1","key":"864_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJ Bradley","year":"2003","unstructured":"Bradley KJ, Wass JA, Turner HE (2003) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol 58(1):59\u201364","journal-title":"Clin Endocrinol"},{"issue":"9","key":"864_CR47","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.humpath.2004.04.016","volume":"35","author":"JA Lopez","year":"2004","unstructured":"Lopez JA, Kleinschmidt-Demasters Bk B, Sze CI, Woodmansee WW, Lillehei KO (2004) Silent corticotroph adenomas: further clinical and pathological observations. Hum Pathol 35(9):1137\u20131147","journal-title":"Hum Pathol"},{"issue":"8","key":"864_CR48","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","volume":"154","author":"H Alahmadi","year":"2012","unstructured":"Alahmadi H, Lee D, Wilson JR, Hayhurst C, Mete O, Gentili F, Asa SL, Zadeh G (2012) Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien) 154(8):1493\u20131498. \n                    https:\/\/doi.org\/10.1007\/s00701-012-1378-1","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"864_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","volume":"135","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar O, Xu Z, Lee CC, Wu CC, Chytka T, Silva D, Sharma M, Radwan H, Grills IS, Nguyen B, Siddiqui Z, Mathieu D, Iorio-Morin C, Wolf A, Cifarelli CP, Cifarelli DT, Lunsford LD, Kondziolka D, Sheehan JP (2017) Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J Neurooncol 135(1):67\u201374. \n                    https:\/\/doi.org\/10.1007\/s11060-017-2520-y","journal-title":"J Neurooncol"},{"issue":"2","key":"864_CR50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"Cooper O (2015) Silent corticotroph adenomas. Pituitary 18(2):225\u2013231. \n                    https:\/\/doi.org\/10.1007\/s11102-014-0624-3","journal-title":"Pituitary"},{"issue":"5","key":"864_CR51","first-page":"197","volume":"20","author":"J Tourniaire","year":"1991","unstructured":"Tourniaire J (1991) [The so-called silent corticotropic pituitary adenoma]. Presse Med 20(5):197\u2013198","journal-title":"Presse Med"},{"issue":"4","key":"864_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11102-017-0809-7","volume":"20","author":"AF Cheres","year":"2017","unstructured":"Cheres AF, ElAsmar N, Rajpal A, Selman WR, Arafah BM (2017) Perioperative hypothalamic pituitary adrenal function in patients with silent corticotroph adenomas. Pituitary 20(4):471\u2013476. \n                    https:\/\/doi.org\/10.1007\/s11102-017-0809-7","journal-title":"Pituitary"},{"issue":"6","key":"864_CR53","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1210\/jcem-65-6-1296","volume":"65","author":"M Reincke","year":"1987","unstructured":"Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W (1987) A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing\u2019s disease. J Clin Endocrinol Metab 65(6):1296\u20131300. \n                    https:\/\/doi.org\/10.1210\/jcem-65-6-1296","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"864_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1023\/B:PITU.0000011172.26649.df","volume":"6","author":"RL Oliver","year":"2003","unstructured":"Oliver RL, Davis JR, White A (2003) Characterisation of ACTH related peptides in ectopic Cushing\u2019s syndrome. Pituitary 6(3):119\u2013126","journal-title":"Pituitary"},{"issue":"1","key":"864_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11060-010-0302-x","volume":"102","author":"L Chen","year":"2011","unstructured":"Chen L, White WL, Spetzler RF, Xu B (2011) A prospective study of nonfunctioning pituitary adenomas: presentation, management, and clinical outcome. J Neurooncol 102(1):129\u2013138. \n                    https:\/\/doi.org\/10.1007\/s11060-010-0302-x","journal-title":"J Neurooncol"},{"issue":"8","key":"864_CR56","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/jc.2015-1764","volume":"100","author":"NC van Varsseveld","year":"2015","unstructured":"van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML (2015) Tumor recurrence or regrowth in adults with nonfunctioning pituitary adenomas using GH replacement therapy. J Clin Endocrinol Metab 100(8):3132\u20133139. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1764","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"864_CR57","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cen.13141","volume":"85","author":"MW O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly MW, Reulen RC, Gupta S, Thompson CA, Dineen R, Goulden EL, Bugg G, Pearce H, Toogood AA, Gittoes NJ, Mitchell R, Thompson CJ, Ayuk J (2016) ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres. Clin Endocrinol 85(5):748\u2013756. \n                    https:\/\/doi.org\/10.1111\/cen.13141","journal-title":"Clin Endocrinol"},{"issue":"7","key":"864_CR58","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/jc.2015-1475","volume":"100","author":"DS Olsson","year":"2015","unstructured":"Olsson DS, Nilsson AG, Bryngelsson IL, Trimpou P, Johannsson G, Andersson E (2015) Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish nationwide study. J Clin Endocrinol Metab 100(7):2651\u20132658. \n                    https:\/\/doi.org\/10.1210\/jc.2015-1475","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"864_CR59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/EJE-15-0967","volume":"174","author":"G Ntali","year":"2016","unstructured":"Ntali G, Capatina C, Fazal-Sanderson V, Byrne JV, Cudlip S, Grossman AB, Wass JA, Karavitaki N (2016) Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up. Eur J Endocrinol 174(2):137\u2013145. \n                    https:\/\/doi.org\/10.1530\/EJE-15-0967","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"864_CR60","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1046\/j.1440-1789.2001.00409.x","volume":"21","author":"S Yokoyama","year":"2001","unstructured":"Yokoyama S, Kawahara Y, Sano T, Nakayama M, Kitajima S-i, Kuratsu J-i (2001) A case of non-functioning pituitary adenoma with Cushing\u2019s syndrome upon recurrence. Neuropathology 21(4):288\u2013293","journal-title":"Neuropathology"},{"issue":"2","key":"864_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2265.1985.tb01076.x","volume":"22","author":"NJ Vaughan","year":"1985","unstructured":"Vaughan NJ, Laroche CM, Goodman I, Davies MJ, Jenkins JS (1985) Pituitary Cushing\u2019s disease arising from a previously non-functional corticotrophic chromophobe adenoma. Clin Endocrinol 22(2):147\u2013153","journal-title":"Clin Endocrinol"},{"issue":"6","key":"864_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/BF03348769","volume":"15","author":"B Ambrosi","year":"1992","unstructured":"Ambrosi B, Colombo P, Bochicchio D, Bassetti M, Masini B, Faglia G (1992) The silent corticotropinoma: is clinical diagnosis possible? J Endocrinol Invest 15(6):443\u2013452","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"864_CR63","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1001\/archinte.1983.00350050206041","volume":"143","author":"EL Gogel","year":"1983","unstructured":"Gogel EL, Salber PR, Tyrrell JB, Rosenblum ML, Findling JW (1983) Cushing\u2019s disease in a patient with a \u2018nonfunctioning\u2019 pituitary tumor. Spontaneous development and remission. Arch Intern Med 143(5):1040\u20131042","journal-title":"Arch Intern Med"},{"issue":"5","key":"864_CR64","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/S0004-27302005000500007","volume":"49","author":"J Abucham","year":"2005","unstructured":"Abucham J, Vieira TC (2005) [Glycoprotein-secreting pituitary adenomas: pathogenesis, diagnosis and treatment]. Arq Bras Endocrinol Metabol 49(5):657\u2013673","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"864_CR65","doi-asserted-by":"publisher","first-page":"E144","DOI":"10.1227\/NEU.0b013e3182750850","volume":"72","author":"E Melcescu","year":"2013","unstructured":"Melcescu E, Gannon AW, Parent AD, Fratkin JF, Nicholas WC, Koch CA, Galhom A (2013) Silent or subclinical corticotroph pituitary macroadenoma transforming into Cushing disease: 11-year follow-up. Neurosurgery 72(1):E144\u2013E146. \n                    https:\/\/doi.org\/10.1227\/NEU.0b013e3182750850","journal-title":"Neurosurgery"},{"issue":"9","key":"864_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1055\/s-2007-984437","volume":"115","author":"T Psaras","year":"2007","unstructured":"Psaras T, Honegger J, Buslei R, Saeger W, Klein D, Capper D, Meyermann R, Mittelbronn M (2007) Atypical type II silent corticotrophic adenoma developing into Cushing\u2019s disease upon second recurrence. Exp Clin Endocrinol Diabetes 115(9):610\u2013615. \n                    https:\/\/doi.org\/10.1055\/s-2007-984437","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"864_CR67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11102-011-0363-7","volume":"15","author":"AK Annamalai","year":"2012","unstructured":"Annamalai AK, Dean AF, Kandasamy N, Kovacs K, Burton H, Halsall DJ, Shaw AS, Antoun NM, Cheow HK, Kirollos RW, Pickard JD, Simpson HL, Jefferies SJ, Burnet NG, Gurnell M (2012) Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature. Pituitary 15(3):276\u2013287. \n                    https:\/\/doi.org\/10.1007\/s11102-011-0363-7","journal-title":"Pituitary"},{"issue":"2","key":"864_CR68","first-page":"272","volume":"60","author":"L He","year":"2016","unstructured":"He L, Forbes JA, Carr K, Highfield NH, Utz A, Moots P, Weaver K (2016) Response of silent corticotroph pituitary carcinoma to chemotherapy: case report. J Neurosurg Sci 60(2):272\u2013280","journal-title":"J Neurosurg Sci"},{"issue":"2","key":"864_CR69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.14310\/horm.2002.1307","volume":"10","author":"O Moshkin","year":"2011","unstructured":"Moshkin O, Syro LV, Scheithauer BW, Ortiz LD, Fadul CE, Uribe H, Gonzalez R, Cusimano M, Horvath E, Rotondo F, Kovacs K (2011) Aggressive silent corticotroph adenoma progressing to pituitary carcinoma: the role of temozolomide therapy. Hormones 10(2):162\u2013167","journal-title":"Hormones"},{"issue":"4","key":"864_CR70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00000478-200304000-00007","volume":"27","author":"F Roncaroli","year":"2003","unstructured":"Roncaroli F, Scheithauer BW, Young WF, Horvath E, Kovacs K, Kros JM, Al-Sarraj S, Lloyd RV, Faustini-Fustini M (2003) Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. Am J Surg Pathol 27(4):477\u2013486","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"864_CR71","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1023\/A:1026233927714","volume":"6","author":"WE Farrell","year":"2003","unstructured":"Farrell WE, Coll AP, Clayton RN, Harris PE (2003) Corticotroph carcinoma presenting as a silent corticotroph adenoma. Pituitary 6(1):41\u201347","journal-title":"Pituitary"},{"issue":"3","key":"864_CR72","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11102-011-0346-8","volume":"15","author":"LD Ortiz","year":"2012","unstructured":"Ortiz LD, Syro LV, Scheithauer BW, Ersen A, Uribe H, Fadul CE, Rotondo F, Horvath E, Kovacs K (2012) Anti-VEGF therapy in pituitary carcinoma. Pituitary 15(3):445\u2013449. \n                    https:\/\/doi.org\/10.1007\/s11102-011-0346-8","journal-title":"Pituitary"},{"issue":"4","key":"864_CR73","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","volume":"90","author":"Z Xu","year":"2014","unstructured":"Xu Z, Ellis S, Lee CC, Starke RM, Schlesinger D, Lee Vance M, Lopes MB, Sheehan J (2014) Silent corticotroph adenomas after stereotactic radiosurgery: a case-control study. Int J Radiat Oncol Biol Phys 90(4):903\u2013910. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"864_CR74","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-014-1702-0","volume":"122","author":"F Ceccato","year":"2015","unstructured":"Ceccato F, Lombardi G, Manara R, Emanuelli E, Denaro L, Milanese L, Gardiman MP, Bertorelle R, Scanarini M, D\u2019Avella D, Occhi G, Boscaro M, Zagonel V, Scaroni C (2015) Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. J Neurooncol 122(1):189\u2013196. \n                    https:\/\/doi.org\/10.1007\/s11060-014-1702-0","journal-title":"J Neurooncol"},{"issue":"1","key":"864_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/eje.0.1490017","volume":"149","author":"M Andersen","year":"2003","unstructured":"Andersen M, Hagen C, Frystyk J, Schroeder HD (2003) Development of acromegaly in patients with prolactinomas. Eur J Endocrinol 149(1):17\u201322","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"864_CR76","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1530\/EJE-16-0979","volume":"176","author":"H Lasolle","year":"2017","unstructured":"Lasolle H, Cortet C, Castinetti F, Cloix L, Caron P, Delemer B, Desailloud R, Jublanc C, Lebrun-Frenay C, Sadoul JL, Taillandier L, Batisse-Lignier M, Bonnet F, Bourcigaux N, Bresson D, Chabre O, Chanson P, Garcia C, Haissaguerre M, Reznik Y, Borot S, Villa C, Vasiljevic A, Gaillard S, Jouanneau E, Assie G, Raverot G (2017) Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. Eur J Endocrinol 176(6):769\u2013777. \n                    https:\/\/doi.org\/10.1530\/EJE-16-0979","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"864_CR77","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3171\/jns.2006.104.6.884","volume":"104","author":"K Arita","year":"2006","unstructured":"Arita K, Tominaga A, Sugiyama K, Eguchi K, Iida K, Sumida M, Migita K, Kurisu K (2006) Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. J Neurosurg 104(6):884\u2013891. \n                    https:\/\/doi.org\/10.3171\/jns.2006.104.6.884","journal-title":"J Neurosurg"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-018-0864-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-018-0864-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T15:54:39Z","timestamp":1589730879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-018-0864-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1007\/s11102-018-0864-8","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"assertion":[{"value":"17 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}